A Study of TAK-662 for Japanese Patients With Congenital Protein C Deficiency

Clinical trial NCT04984889 · COMPLETED

Trial details

NCT number: NCT04984889
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Congenital Protein C Deficiency

Start date: 2021-09-07
Primary completion: 2022-03-29
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.